No paralogue variants have been mapped to residue 1639 for SCN5A.
SCN5A | -----KYFFSPTLFRVIRLARIGRILRLIR>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1669 |
SCN1A | -----KYFVSPTLFRVIRLARIGRILRLIK>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1682 |
SCN2A | -----KYFVSPTLFRVIRLARIGRILRLIK>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1672 |
SCN3A | -----KYFVSPTLFRVIRLARIGRILRLIK>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1667 |
SCN4A | -----KYFVSPTLFRVIRLARIGRVLRLIR>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1494 |
SCN7A | -----SYLVPPSLVQLILLSRIIHMLRLGK>G<PKVFHNLMLPLMLSLPALLNIILLIFLVMF | 1392 |
SCN8A | -----KYFVSPTLFRVIRLARIGRILRLIK>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1663 |
SCN9A | -----TYFVSPTLFRVIRLARIGRILRLVK>G<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1645 |
SCN10A | ----LQSYFSPTLFRVIRLARIGRILRLIR>A<AKGIRTLLFALMMSLPALFNIGLLLFLVMF | 1619 |
SCN11A | ----EHIPFPPTLFRIVRLARIGRILRLVR>A<ARGIRTLLFALMMSLPSLFNIGLLLFLIMF | 1509 |
CACNA1A | -------FINLSFLRLFRA---ARLIKLLR>Q<GYTIRILLWTFVQSFKALPYVCLLIAMLFF | 1704 |
CACNA1B | -----NNFINLSFLRLFRA---ARLIKLLR>Q<GYTIRILLWTFVQSFKALPYVCLLIAMLFF | 1612 |
CACNA1C | MNAEENSRISITFFRLFRV---MRLVKLLS>R<GEGIRTLLWTFIKSFQALPYVALLIVMLFF | 1372 |
CACNA1D | GNSEESNRISITFFRLFRV---MRLVKLLS>R<GEGIRTLLWTFIKSFQALPYVALLIAMLFF | 1382 |
CACNA1E | ----NTSGFNMSFLKLFRA---ARLIKLLR>Q<GYTIRILLWTFVQSFKALPYVCLLIAMLFF | 1619 |
CACNA1F | -SSEDSSRISITFFRLFRV---MRLVKLLS>K<GEGIRTLLWTFIKSFQALPYVALLIAMIFF | 1339 |
CACNA1G | ----ASLPINPTIIRIMRVLRIARVLKLLK>M<AVGMRALLDTVMQALPQVGNLGLLFMLLFF | 1755 |
CACNA1H | ----AALPINPTIIRIMRVLRIARVLKLLK>M<ATGMRALLDTVVQALPQVGNLGLLFMLLFF | 1761 |
CACNA1I | ----AALPINPTIIRIMRVLRIARVLKLLK>M<ATGMRALLDTVVQALPQVGNLGLLFMLLFF | 1631 |
CACNA1S | VDPDESARISSAFFRLFRV---MRLIKLLS>R<AEGVRTLLWTFIKSFQALPYVALLIVMLFF | 1279 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.G1639A | c.4916G>C | Putative Benign | rs370819854 | SIFT: tolerated Polyphen: possibly damaging |